AGIOS PHARMACEUTICALS, INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$10.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $8.35M, a 42.50% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$19.17M.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $8.24M, a 39.19% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $1.93M.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$1.40M, a 137.95% decline from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $3.69M, a 71.18% decline from fiscal 2023.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $12.82M.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$1.62M, a 2550.00% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$10.81M 10-Q · filed 2026-07-30 | -$2.57M derived: sum of 3 quarters · filed 2026-07-30 | -$642.00K derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$19.17M 10-Q · filed 2026-04-29 | -$10.92M derived: sum of 2 quarters · filed 2026-04-29 | -$9.00M derived: sum of 3 quarters · filed 2026-04-29 | $5.53M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $8.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $10.17M derived: sum of 2 quarters · filed 2026-02-12 | $24.70M derived: sum of 3 quarters · filed 2026-07-30 | -$1.40M 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $16.46M derived: sum of 2 quarters · filed 2026-07-30 | -$9.64M 10-Q · filed 2025-10-30 | $3.91M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $14.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$11.57M 10-Q · filed 2026-07-30 | $1.98M derived: sum of 3 quarters · filed 2026-07-30 | -$1.45M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$26.10M 10-Q · filed 2026-04-29 | -$12.55M derived: sum of 2 quarters · filed 2026-04-29 | -$15.98M derived: sum of 3 quarters · filed 2026-04-29 | -$4.37M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $13.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $10.12M derived: sum of 2 quarters · filed 2026-02-12 | $21.73M derived: sum of 3 quarters · filed 2026-02-12 | $3.69M 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | -$3.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $8.18M derived: sum of 2 quarters · filed 2025-10-30 | -$9.86M 10-Q · filed 2025-10-30 | $2.82M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | $11.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$6.42M 10-Q · filed 2025-07-31 | $6.25M derived: sum of 3 quarters · filed 2026-02-12 | $7.55M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | -$18.04M 10-Q · filed 2025-05-01 | -$5.36M derived: sum of 2 quarters · filed 2026-02-12 | -$4.06M derived: sum of 3 quarters · filed 2026-02-12 | $2.67M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | $12.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $13.98M derived: sum of 2 quarters · filed 2026-02-12 | $20.71M derived: sum of 3 quarters · filed 2026-02-12 | $12.82M 10-K · filed 2026-02-12 | ||||
| 2023-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $8.03M derived: sum of 2 quarters · filed 2024-10-31 | $140.00K 10-Q · filed 2024-10-31 | $734.00K derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $6.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$1.16M 10-Q · filed 2024-08-01 | -$567.00K derived: sum of 3 quarters · filed 2025-02-13 | $806.00K derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | -$7.89M 10-Q · filed 2024-05-02 | -$7.30M derived: sum of 2 quarters · filed 2025-02-13 | -$5.92M derived: sum of 3 quarters · filed 2025-02-13 | $2.71M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $594.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $1.97M derived: sum of 2 quarters · filed 2025-02-13 | $10.60M derived: sum of 3 quarters · filed 2025-02-13 | -$1.62M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $10.01M derived: sum of 2 quarters · filed 2023-11-02 | -$2.21M 10-Q · filed 2023-11-02 | $522.00K derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $8.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$3.58M 10-Q · filed 2023-08-03 | -$851.00K derived: sum of 3 quarters · filed 2024-02-15 | -$971.00K derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | -$12.22M 10-Q · filed 2023-05-04 | -$9.49M derived: sum of 2 quarters · filed 2024-02-15 | -$9.61M derived: sum of 3 quarters · filed 2024-02-15 | $543.00K derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $2.61M derived: sum of 2 quarters · filed 2024-02-15 | $12.76M derived: sum of 3 quarters · filed 2024-02-15 | $66.00K 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | -$120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $10.03M derived: sum of 2 quarters · filed 2022-11-03 | -$2.67M 10-Q · filed 2022-11-03 | $5.42M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $10.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$2.55M 10-Q · filed 2022-08-04 | $5.54M derived: sum of 3 quarters · filed 2023-02-23 | $12.48M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | -$12.70M 10-Q · filed 2022-05-05 | -$4.62M derived: sum of 2 quarters · filed 2023-02-23 | $2.33M derived: sum of 3 quarters · filed 2023-02-23 | $5.04M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $8.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $15.03M derived: sum of 2 quarters · filed 2023-02-23 | $17.74M derived: sum of 3 quarters · filed 2023-02-23 | $6.76M 10-K · filed 2023-02-23 | $10.76M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $6.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $9.65M derived: sum of 2 quarters · filed 2021-11-03 | -$1.32M 10-Q · filed 2021-11-03 | $162.00K 10-Q · filed 2020-11-05 | -$6.74M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $2.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$8.27M 10-Q · filed 2021-07-29 | -$8.60M 10-Q · filed 2020-07-30 | -$13.69M derived: sum of 3 quarters · filed 2022-02-24 | -$16.16M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | -$10.97M 10-Q · filed 2021-04-29 | -$14.97M 10-Q · filed 2020-04-30 | -$16.40M derived: sum of 2 quarters · filed 2022-02-24 | -$18.87M derived: sum of 3 quarters · filed 2022-02-24 | -$6.70M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | -$5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$7.90M derived: sum of 2 quarters · filed 2022-02-24 | $4.27M derived: sum of 3 quarters · filed 2022-02-24 | -$825.00K 10-K · filed 2022-02-24 | $7.23M 10-K · filed 2020-02-19 | |||
| 2019-09-30 | -$2.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $9.70M derived: sum of 2 quarters · filed 2020-11-05 | $4.60M 10-Q · filed 2020-11-05 | $21.76M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $12.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $7.07M 10-Q · filed 2020-07-30 | $24.23M derived: sum of 3 quarters · filed 2021-02-25 | $23.54M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$5.10M 10-Q · filed 2020-04-30 | $12.06M derived: sum of 2 quarters · filed 2021-02-25 | $11.37M derived: sum of 3 quarters · filed 2021-02-25 | $20.67M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $17.16M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $16.46M derived: sum of 2 quarters · filed 2021-02-25 | $25.77M derived: sum of 3 quarters · filed 2021-02-25 | $8.62M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$696.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $8.61M derived: sum of 2 quarters · filed 2019-10-31 | -$8.54M 10-Q · filed 2019-10-31 | -$5.77M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $9.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$7.84M 10-Q · filed 2019-08-01 | -$5.08M derived: sum of 3 quarters · filed 2020-02-19 | -$3.93M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | -$17.14M 10-Q · filed 2019-05-02 | -$14.38M derived: sum of 2 quarters · filed 2020-02-19 | -$13.23M derived: sum of 3 quarters · filed 2020-02-19 | -$8.73M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $3.91M derived: sum of 2 quarters · filed 2020-02-19 | $8.41M derived: sum of 3 quarters · filed 2020-02-19 | $1.52M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $5.65M derived: sum of 2 quarters · filed 2018-11-01 | -$1.24M 10-Q · filed 2018-11-01 | $8.28M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-06-30 | $4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$2.39M 10-Q · filed 2018-08-02 | $7.13M derived: sum of 3 quarters · filed 2019-02-14 | $15.29M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-03-31 | -$6.89M 10-Q · filed 2018-05-04 | $2.64M derived: sum of 2 quarters · filed 2019-02-14 | $10.80M derived: sum of 3 quarters · filed 2019-02-14 | $12.87M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2016-12-31 | $9.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $17.69M derived: sum of 2 quarters · filed 2019-02-14 | $19.76M derived: sum of 3 quarters · filed 2019-02-14 | $16.85M 10-K · filed 2019-02-14 | ||||
| 2016-09-30 | $8.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $10.23M derived: sum of 2 quarters · filed 2017-11-01 | $7.33M 10-Q · filed 2017-11-01 | $6.49M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$833.00K 10-Q · filed 2017-08-08 | -$1.67M derived: sum of 3 quarters · filed 2018-02-14 | $3.36M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-03-31 | -$2.90M 10-Q · filed 2017-05-04 | -$3.74M derived: sum of 2 quarters · filed 2018-02-14 | $1.29M derived: sum of 3 quarters · filed 2018-02-14 | -$2.84M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2015-12-31 | -$836.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $4.19M derived: sum of 2 quarters · filed 2018-02-14 | $59.00K derived: sum of 3 quarters · filed 2018-02-14 | $1.63M 10-K · filed 2018-02-14 | ||||
| 2015-09-30 | $5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $895.00K derived: sum of 2 quarters · filed 2016-11-03 | $2.47M 10-Q · filed 2016-11-03 | $4.29M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | -$4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$2.56M 10-Q · filed 2016-08-08 | -$741.00K derived: sum of 3 quarters · filed 2017-02-16 | $3.80M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | $1.57M 10-Q · filed 2016-05-09 | $3.39M derived: sum of 2 quarters · filed 2017-02-16 | $7.93M derived: sum of 3 quarters · filed 2017-02-16 | $9.00M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $6.36M derived: sum of 2 quarters · filed 2017-02-16 | $7.42M derived: sum of 3 quarters · filed 2017-02-16 | $5.23M 10-K · filed 2017-02-16 | ||||
| 2014-09-30 | $4.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $5.61M derived: sum of 2 quarters · filed 2015-11-06 | $3.41M 10-Q · filed 2015-11-06 | $5.81M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$1.13M 10-Q · filed 2015-08-07 | $1.27M derived: sum of 3 quarters · filed 2016-02-26 | $1.90M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | -$2.19M 10-Q · filed 2015-05-11 | $204.00K derived: sum of 2 quarters · filed 2016-02-26 | $839.00K derived: sum of 3 quarters · filed 2016-02-26 | $2.38M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $3.03M derived: sum of 2 quarters · filed 2016-02-26 | $4.58M derived: sum of 3 quarters · filed 2016-02-26 | $4.88M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $635.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $2.18M derived: sum of 2 quarters · filed 2014-11-07 | $2.48M 10-Q · filed 2014-11-07 | $2.23M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.84M 10-Q · filed 2014-08-07 | $1.60M derived: sum of 3 quarters · filed 2015-02-24 | $1.23M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $301.00K 10-Q · filed 2014-05-09 | $53.00K derived: sum of 2 quarters · filed 2015-02-24 | -$313.00K derived: sum of 3 quarters · filed 2015-02-24 | |||||
| 2012-12-31 | -$248.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$614.00K derived: sum of 2 quarters · filed 2015-02-24 | $156.00K 10-K · filed 2015-02-24 | |||||
| 2012-09-30 | -$366.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $404.00K 10-Q · filed 2013-11-07 | ||||||
| 2012-06-30 | $770.00K 10-Q · filed 2013-09-05 | |||||||
| 2011-12-31 | $525.00K 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |